2. Amyotrophic lateral sclerosis Clinical trials / Disease details

Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03204500 (ClinicalTrials.gov)	May 2016	28/6/2017	Dual Treatment With Lithium and Valproate in ALS.	A Randomized Clinical Trial, Double Blind, Placebo-controlled of Lithium and Valproate in Amyotrophic Lateral Sclerosis.	Amyotrophic Lateral Sclerosis;Amyotrophic Lateral Sclerosis, Sporadic	Combination Product: Active treatment with dual therapy;Drug: Placebos	El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez	NULL	Completed	40 Years	70 Years	All	43	Phase 2	Mexico
2	NCT00136110 (ClinicalTrials.gov)	April 2005	24/8/2005	Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis	A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS	Amyotrophic Lateral Sclerosis	Drug: Sodium Valproate	UMC Utrecht	Princess Beatrix Fund, The Netherlands	Completed	18 Years	85 Years	Both	165	Phase 3	Netherlands